April 21, 2026 – McKesson Company introduced that it has entered right into a definitive settlement with funds managed by associates of Apollo (“Apollo Funds”) underneath which Apollo Funds will purchase a minority curiosity in McKesson’s Medical-Surgical Options (“MMS”) enterprise. This transaction represents a significant milestone as McKesson executes its separation technique from MMS in preparation for a deliberate preliminary public providing.

Apollo Funds will make investments $1.25 billion in MMS convertible most popular inventory to accumulate an roughly 13% minority stake in MMS. The transaction values ​​MMS at a complete enterprise worth of roughly $13 billion. McKesson retains operational management and majority possession of MMS and consolidates outcomes for monetary reporting. The transaction is topic to regulatory approval and customary closing circumstances.

Learn extra in regards to the press launch right here.